Abstract
Among the great challenges facing clinical research is the development of bioactive surgical additives regulating inflammation and increasing healing. Although the use of fibrin adhesives and platelet-rich plasma (PRP) is well documented, they have their own limitations. Hence, reconstructive dental surgeons are looking for an “edge” that jump starts the healing process to maximize predictability as well as the volume of regenerated bone. Overcoming the restrictions related to the reimplantation of blood-derived products, a new family of platelet concentrate, which is neither a fibrin glue nor a classical platelet concentrate, was developed in France. This second generation platelet concentrate called platelet-rich fibrin (PRF), has been widely used to accelerate soft and hard tissue healing. Its advantages over the better known PRP include ease of preparation/application, minimal expense, and lack of biochemical modification (no bovine thrombin or anticoagulant is required). This article serves as an introduction to the PRF “concept” and its potential clinical applications with emphasis on periodontal regeneration.



Similar content being viewed by others
Abbreviations
- ALP:
-
Alkaline phosphatase
- CCE:
-
Crestal core elevation
- CD:
-
Cluster of Differentiation
- cPRP:
-
Concentrated platelet-rich plasma
- CR3:
-
Complement Receptor 3
- FDBA:
-
Freeze-dried bone allograft
- FDPs:
-
Fibrinogen degradation products
- GBR:
-
Guided bone regeneration
- IGF:
-
Insulin-like growth factor
- IL:
-
Interleukin
- IL-1Ra:
-
Interleukin-1 receptor antagonist
- L-PRF:
-
Leucocyte- and platelet-rich fibrin
- MCAF:
-
Modified coronally advanced flap
- OFD:
-
Open flap debridement
- OMSFE:
-
Osteotome-mediated sinus floor elevation
- OPG:
-
Osteoprotegrin
- PDGF:
-
Platelet-derived growth factor
- p-ERK:
-
Phosphorylated extracellular signal-regulated protein kinase
- PPP:
-
Platelet-poor plasma
- PRF:
-
Platelet-rich fibrin
- PRFe:
-
PRF extract
- PRFM:
-
Platelet-rich fibrin matrix
- PRP:
-
Platelet-rich plasma
- RBCs:
-
Red blood cells
- TGF:
-
Transforming growth factor
- TNF:
-
Tumor necrosis factor
- VEGF:
-
Vascular endothelial growth factor
- WBCs:
-
White blood cells
References
Anilkumar K, Geetha A, Umasudhakar TR, Ramakrishnan T, Vijayalakshmi R, Pameela E (2009) Platelet-rich-fibrin: a novel root coverage approach. J Indian Soc Periodontol 13:50–54
Aroca S, Keglevich T, Barbieri B, Gera I, Etienne D (2009) Clinical evaluation of a modified coronally advanced flap alone or in combination with a platelet-rich fibrin membrane for the treatment of adjacent multiple gingival recessions: a 6-month study. J Periodontol 80:244–252
Braccini F, Dohan DM (2007) The relevance of Choukroun’s platelet rich fibrin (PRF) during facial aesthetic lipostructure (Coleman’s technique): preliminary results (in French). Rev Laryngol Otol Rhinol (Bord) 128:255–260
Braccini F, Tardivet L, Dohan Ehrenfest DM (2009) The relevance of Choukroun’s platelet-rich fibrin (PRF) during middle ear surgery: preliminary results. Rev Laryngol Otol Rhinol (Bord) 130:175–180
Carlson NE, Roach RB Jr (2002) Platelet-rich plasma: clinical applications in dentistry. J Am Dent Assoc 133:1383–1386
Chang Y-C, Zhao J-H (2011) Effects of platelet-rich fibrin on human periodontal ligament fibroblasts and application for periodontal infrabony defects. Aust Dent J 56:365–371
Chang I-C, Tsai C-H, Chang Y-C (2010) Platelet-rich fibrin modulates the expression of extracellular signal-regulated protein kinase and osteoprotegerin in human osteoblasts. J Biomed Mater Res 95A:327–332
Chang Y-C, Wu K-C, Zhao J-H (2011) Clinical application of platelet-rich fibrin as the sole grafting material in periodontal intrabony defects. J Dent Sci 6:181–188
Charrier JB, Monteil JP, Albert S, Collon S, Bobin S, Dohan Ehrenfest DM (2008) Relevance of Choukroun’s platelet-rich fibrin (PRF) and SMAS flap in primary reconstruction after superficial or subtotal parotidectomy in patients with focal pleiomorphic adenoma: a new technique. Rev Laryngol Otol Rhinol (Bord) 129:313–318
Choukroun J, Diss A, Simonpieri A, Girard MO, Schoeffler C, Dohan SL, Dohan AJ, Mouhyi J, Dohan DM (2006a) Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part IV: clinical effects on tissue healing. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 101:E56–E60
Choukroun J, Diss A, Simonpieri A, Girard MO, Schoeffler C, Dohan SL, Dohan AJ, Mouhyi J, Dohan DM (2006b) Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part V: histologic evaluations of PRF effects on bone allograft maturation in sinus lift. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 101:299–303
Choukroun JI, Braccini F, Diss A, Giordano G, Doglioli P, Dohan DM (2007) Influence of platelet rich fibrin (PRF) on proliferation of human preadipocytes and tympanic keratinocytes: a new opportunity in facial lipostructure (Coleman’s technique) and tympanoplasty? Rev Laryngol Otol Rhinol (Bord) 128:27–32
Clark RA (2001) Fibrin and wound healing. Ann N Y Acad Sci 936:355–367
Danielsen PL (2008) Platelet-rich fibrin in human acute wound models. PhD Thesis, University of Copenhagen
Del Corso M, Toffler M, Dohan Ehrenfest DM (2010) Use of an autologous leukocyte and platelet-rich fibrin (L-PRF) membrane in post-avulsion sites: an overview of Choukroun’s PRF. J Implant Adv Clin Dent 1:27–35
Dohan DM, Choukroun J, Diss A, Dohan SL, Dohan AJ, Mouhyi J, Gogly B (2006a) Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part I: technological concepts and evolution. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 101:E37–E44
Dohan DM, Choukroun J, Diss A, Dohan SL, Dohan AJ, Mouhyi J, Gogly B (2006b) Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part II: platelet-related biologic features. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 101:E45–E50
Dohan DM, Choukroun J, Diss A, Dohan SL, Dohan AJ, Mouhyi J, Gogly B (2006c) Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part III: leucocyte activation: a new feature for platelet concentrates? Oral Surg Oral Med Oral Pathol Oral Radiol Endod 101:E51–E55
Dohan DM, Corso MD, Diss A, Mouhyi J, Charrier JB (2010) Three-dimensional architecture and cell composition of a Choukroun’s platelet-rich fibrin clot and membrane. J Periodontol 81:546–555
Dohan Ehrenfest DM, Rasmusson L, Albrektsson T (2009) Classification of platelet concentrates: from pure patelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). Trends Biotechnol 27:158–167
Gassling V, Douglas T, Warnke PH, Acil Y, Wiltfang J, Becker ST (2010) Platelet-rich fibrin membranes as scaffolds for periosteal tissue engineering. Clin Oral Implants Res 21:543–549
Goldsby RA, Kindt TJ, Osborne BA, Kuby J (2003) Cytokines. In: Goldsby RA, Kindt TJ, Osborne BA, Kuby J (eds) Immunology, 5th edn. W.H. Freeman & Company, New York, pp 276–298
He L, Lin Y, Hu X, Zhang Y, Wu H (2009) A comparative study of platelet-rich fibrin (PRF) and platelet-rich plasma (PRP) on the effect of proliferation and differentiation of rat osteoblasts in vitro. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 108:707–713
Huang F-M, Yang S-F, Zhao J-H, Chang Y-C (2010) Platelet-rich fibrin increases proliferation and differentiation of human dental pulp cells. J Endod 36:1628–1632
Ikram N, Hassan K, Tufail S (2004) Cytokines. Int J Pathol 2:47–58
Inchingolo F, Tatullo M, Marrelli M, Inchingolo AM, Scacco S, Inchingolo AD, Dipalma G, Vermesan D, Abbinante A, Cagiano R (2010) Trial with platelet-rich fibrin and bio-Oss used as grafting materials in the treatment of the severe maxillary bone atrophy: clinical and radiological evaluations. Eur Rev Med Pharmacol Sci 14:1075–1084
Jameson CA (2007) Autologous platelet concentrate for the production of platelet gel. Lab Med 38:39–42
Kang Y-H, Jeon SH, Park J-Y, Chung J-H, Choung Y-H, Choung H-W, Kim E-S, Choung P-H (2011) Platelet-rich fibrin is a Bioscaffold and reservoir of growth factors for tissue regeneration. Tissue Eng Part A 17:349–359
Kishimoto T (1989) The biology of Interleukin-6. Blood 74:1–10
Kishimoto T, Akira S, Narazaki M, Taga T (1995) Interleukin-6 family of cytokines and gp130. Blood 86:1243–1254
Lucarelli E, Beretta R, Dozza B, Tazzari PL, O’ Connell SM, Ricci F, Pierini M, Squarzoni S, Pagliaro PP, Oprita EI, Donati D (2010) A recently developed bifacial platelet-rich fibrin matrix. Euro Cell Mater 20:13–23
Marx RE (2001) Platelet-rich plasma (PRP): what is PRP and what is not PRP? Implant Dent 10:225–228
Marx RE (2004) Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg 62:489–496
Marx RE, Carlson ER, Eichstaedt RM, Schimmele SR, Strauss JE, Georgeff KR (1998) Platelet-rich plasma: growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 85:638–646
Mattuella LG, Bento LW, de Figueiredo JAP, Nör JE, de Araujo FB, Fossati ACM (2007) Vascular endothelial growth factor and its relationship with the dental pulp. J Endod 33:524–530
Mazor Z, Horowitz RA, Del Corso M, Prasad HS, Rohrer MD, Dohan Ehrenfest DM (2009) Sinus floor augmentation with simultaneous implant placement using Choukroun’s platelet-rich fibrin as the sole grafting material: a radiologic and histologic study at 6 months. J Periodontol 80:2056–2064
Pradeep AR, Sharma A (2011a) Autologous platelet rich fibrin in the treatment of mandibular degree II furcation defects: a randomized clinical trial. J Periodontol 82:1396–1403
Pradeep AR, Sharma A (2011b) Treatment of 3-wall intrabony defects in chronic periodontitis subjects with autologous platelet rich fibrin—a randomized controlled clinical trial. J Periodontol. doi:10.1902/jop.2011.110075
Pradeep AR, Rao NS, Agarwal E, Bajaj P (2012) Comparative evaluation of autologous platelet-rich fibrin and platelet-rich plasma in the treatment of three-wall intrabony defects in chronic periodontitis: a randomized controlled clinical trial. J Periodontol. doi:10.1902/jop.2012.110705
Raja SV, Naidu ME (2008) Platelet-rich fibrin: evolution of a second-generation platelet concentrate. Indian J Dent Res 19:42–46
Saluja H, Dehane V, Mahindra U (2011) Platelet-rich fibrin: a second generation platelet concentrate and a new friend of oral and maxillofacial surgeons. Ann Maxillofac Surg 1:53–57
Simon BI, Gupta P, Tajbakhsh S (2011) Quantitative evaluation of extraction socket healing following the use of autologous platelet rich fibrin matrix in humans. Int J Periodontics Restor Dent 31:284–295
Tilg H, Trehu E, Atkins MB, Dinarello CA, Mier JW (1994) Interleukin- (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55. Blood 83:113–118
Toffler M, Toscano N, Holtzclaw D, Corso MD, Dohan DM (2009) Introducing Choukroun’s platelet rich fibrin (PRF) to the reconstructive surgery milieu. J Implant Adv Clin Dent 1:22–31
Tsai C-H, Shen S-Y, Zhao J-H, Chang Y-C (2009) Platelet-rich fibrin modulates cell proliferation of human periodontally related cells in vitro. J Dent Sci 4:130–135
Wu C-L, Lee S–S, Tsai C-H, Lu K-H, Zhao J-H, Chang Y-C (2012) Platelet-rich fibrin increases cell attachment, proliferation and collagen-related protein expression of human osteoblasts. Aust Dent J 57:207–212
Zhao J-H, Tsai C-H, Chang Y-C (2011) Clinical and histologic evaluation of extraction socket healing filled with platelet rich fibrin. J Dent Sci 6:116–122
Zhao J-H, Tsai C-H, Chang Y-C (2012) Management of radicular cysts using platelet-rich fibrin and bioactive glass: a report of two cases. J Formos Med Assoc. doi:10.1016/j.jfma.2011.09.027
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Vinaya Kumar, R., Shubhashini, N. Platelet rich fibrin: a new paradigm in periodontal regeneration. Cell Tissue Bank 14, 453–463 (2013). https://doi.org/10.1007/s10561-012-9349-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10561-012-9349-6